SAR AND QSAR IN ENVIRONMENTAL RESEARCH

Scope & Guideline

Pioneering the Path from Structure to Environmental Impact.

Introduction

Delve into the academic richness of SAR AND QSAR IN ENVIRONMENTAL RESEARCH with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1062-936x
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1993 to 2024
AbbreviationSAR QSAR ENVIRON RES / SAR QSAR Environ. Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'SAR and QSAR in Environmental Research' primarily focuses on the development and application of Quantitative Structure-Activity Relationships (QSAR) and Structure-Activity Relationships (SAR) methodologies in environmental research and related fields. It encompasses a wide range of topics that connect computational models with ecological and toxicological assessments.
  1. QSAR Modeling:
    The journal emphasizes the use of QSAR modeling techniques for predicting the biological activity of chemical compounds, toxicity, and environmental impact based on their chemical structure.
  2. Molecular Dynamics Simulations:
    It incorporates molecular dynamics simulations to understand the interactions at a molecular level, aiding in the design of new compounds and the prediction of their behavior in biological systems.
  3. Toxicity Predictions:
    A core area of research involves predicting the toxicity of various substances, including pharmaceuticals and environmental pollutants, to aquatic and other biological species.
  4. Machine Learning Integration:
    The journal explores the integration of machine learning techniques with traditional QSAR approaches to enhance predictive accuracy and model robustness.
  5. Multi-target Drug Discovery:
    Research often focuses on identifying multi-target inhibitors for diseases, utilizing computational methods to streamline drug discovery processes.
  6. Environmental Risk Assessment:
    It addresses the environmental implications of chemical substances, offering insights into their potential risks and effects on ecosystems.
Recent publications in the journal indicate a clear shift towards innovative methodologies and interdisciplinary approaches that are gaining traction. These emerging themes reflect the evolving landscape of environmental research and computational chemistry.
  1. Machine Learning and AI in QSAR:
    There is a growing trend in applying machine learning and artificial intelligence to enhance QSAR modeling, improving the accuracy and efficiency of predictions related to chemical activities and toxicity.
  2. Integrated Computational Approaches:
    Emerging studies are increasingly combining various computational techniques, such as molecular docking, dynamics simulations, and QSAR, to provide a more holistic understanding of chemical interactions and biological effects.
  3. Environmental Impact of Pharmaceuticals:
    Research focusing on the environmental impact of pharmaceuticals and personal care products is on the rise, highlighting the need for effective risk assessment and management strategies.
  4. Natural Product-Based Inhibitors:
    The exploration of natural compounds as potential inhibitors for various biological targets is gaining momentum, reflecting an interest in sustainable and eco-friendly alternatives in drug discovery.
  5. Predictive Toxicology and Ecotoxicology:
    There is a notable increase in publications addressing predictive toxicology and ecotoxicology, which utilize QSAR models to assess the effects of chemicals on various species and ecosystems.

Declining or Waning

While the journal maintains a robust focus on QSAR and SAR methodologies, certain themes are showing signs of decline in prominence. These waning scopes reflect shifts in research priorities or advancements in methodologies that make previous approaches less prevalent.
  1. Traditional SAR Approaches:
    Traditional SAR methodologies are becoming less dominant as researchers increasingly favor more advanced computational techniques, such as machine learning and deep learning models, which offer better predictive capabilities.
  2. Basic Toxicity Assessments:
    There has been a decline in the number of publications focusing solely on basic toxicity assessments without the integration of advanced modeling techniques, as the field moves towards more comprehensive and predictive approaches.
  3. Single-target Inhibitor Studies:
    Research concentrating on single-target inhibitors is waning in favor of multi-target approaches that can address complex biological systems more effectively.

Similar Journals

TOXICOLOGY LETTERS

Fostering collaboration to combat chemical hazards.
Publisher: ELSEVIER IRELAND LTDISSN: 0378-4274Frequency: 20 issues/year

TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.

ARCHIVES OF TOXICOLOGY

Uncovering Insights, Shaping Safety
Publisher: SPRINGER HEIDELBERGISSN: 0340-5761Frequency: 12 issues/year

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

BIOORGANIC & MEDICINAL CHEMISTRY

Connecting Molecular Insights to Clinical Applications
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0968-0896Frequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

Moroccan Journal of Chemistry

Empowering Chemists with Cutting-Edge Discoveries.
Publisher: UNIV MOHAMMED PREMIER OUJDAISSN: 2351-812XFrequency: 4 issues/year

Moroccan Journal of Chemistry, published by the University Mohammed Premier Oujda, serves as a pivotal platform for researchers and professionals in the field of chemistry, particularly focusing on diverse and emerging areas within the discipline. Established in 2018, this open-access journal facilitates widespread dissemination of scholarly articles, ensuring that cutting-edge research reaches a global audience. With an ISSN of 2351-812X and categorized in the Q3 quartile for miscellaneous chemistry in 2023, the journal maintains rigorous peer-review standards while fostering an inclusive environment for scientific dialogue. Located in Morocco, it aims to bridge local and international research communities, contributing to the advancement of knowledge in chemistry. As it continues to grow, the Moroccan Journal of Chemistry remains an essential resource for students, educators, and professionals eager to stay abreast of the latest developments in the field.

Letters in Drug Design & Discovery

Exploring New Horizons in Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1808Frequency: 12 issues/year

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

MOLECULAR DIVERSITY

Connecting Chemistry, Biology, and Pharmacology for a Better Tomorrow
Publisher: SPRINGERISSN: 1381-1991Frequency: 4 issues/year

MOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.

Chemical Biology Letters

Unlocking Innovations in Biochemistry and Medicine
Publisher: ScienceIn PublicationsISSN: Frequency: 1 issue/year

Chemical Biology Letters is a prominent academic journal dedicated to the evolving field of biochemistry and its applications in medical and clinical contexts. Published by ScienceIn Publications, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing cutting-edge findings and innovations that drive forward our understanding of chemical interactions in biological systems. With its scope ranging from molecular biology to clinical biochemistry, Chemical Biology Letters is committed to advancing knowledge and fostering collaboration within the scientific community. Recognized for its quality, the journal is categorized in Q4 for Biochemistry and Molecular Biology fields, while achieving notably higher ranks in Medical Biochemistry, reflecting its significant contributions to the discipline. Aiming to remain accessible to a diverse audience, the journal is published in open access format, inviting researchers worldwide to explore and share invaluable insights. Established in 2014, it continues to grow in impact and relevance, paving the way for advancements in both theoretical and applied research within the realm of chemical biology.

Current Computer-Aided Drug Design

Exploring New Horizons in Drug Design and Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4099Frequency: 4 issues/year

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

CHEMISTRY LETTERS

Fostering excellence in chemical research and collaboration.
Publisher: CHEMICAL SOC JAPANISSN: 0366-7022Frequency: 12 issues/year

Chemistry Letters, published by the Chemical Society of Japan, is a distinguished academic journal that focuses on pivotal developments in the field of chemistry. Since its inception in 1973, the journal has been a vital platform for the dissemination of novel research findings across various sub-disciplines, encompassing both theoretical advancements and practical applications. As a testament to its significance in the community, Chemistry Letters has achieved a Category Quartile of Q2 in the 2023 ranking for miscellaneous Chemistry journals, reflecting its respected position among peers. Although it does not offer Open Access, the journal remains accessible through institutional subscriptions, thus ensuring a wide reach for its valuable content. With an active scope ranging from general chemistry topics to specialized studies, it is ideal for researchers, professionals, and students alike who seek to contribute to and expand their knowledge within this dynamic field. The journal continuously aims to promote excellence in chemical research, facilitating dialogue and collaboration among chemists worldwide.

Journal of Chemical Information and Modeling

Innovating Chemical Engineering Through Information Modeling.
Publisher: AMER CHEMICAL SOCISSN: 1549-9596Frequency: 12 issues/year

Journal of Chemical Information and Modeling is a premier scholarly publication dedicated to advancing the fields of chemical engineering, chemistry, and computer science applications. Published by the reputable American Chemical Society, this journal significantly contributes to the scientific community through innovative research and critical reviews that facilitate the understanding and application of chemical information. With an impressive impact factor and a distinguished ranking in multiple categories—such as Q1 in Chemical Engineering and Q1 in Chemistry—the journal is an indispensable resource for researchers and professionals alike. As open access is not currently available, the journal preserves a selective distribution model that ensures high-quality content is accessible to a dedicated audience. By exploring the intersections of data science and chemical informatics, the Journal of Chemical Information and Modeling fosters interdisciplinary collaboration and innovation, positioning itself as a leader in its field. Researchers, professionals, and students are encouraged to engage with this influential platform for the latest developments in chemical information science.